COMMUNIQUÉS West-GlobeNewswire

Medirom Decides to Double Installation of Authentication Device “Orb” to 200 Stores, in Collaboration with “World” Co-founded by Sam Altman and Alex Blania
25/09/2025
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM), a diversified healthcare company, has joined “World,” a “proof of human” [...]
Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology
25/09/2025
– KOMET-001 in R/R NPM1 -m AML met its primary endpoint with ziftomenib monotherapy demonstrating significant clinical benefit and deep responses – – Consistent activity across pre-specified subgroups, regardless of [...]
Medicenna Announces Results of Annual Meeting of Shareholders
25/09/2025
TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]
Organogenesis Provides Update on Second Phase 3 ReNu® Study
25/09/2025
Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary [...]
Teva Releases Q3 2025 Aide Memoire
25/09/2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2025 Aide Memoire is available on the “Investors” page on its website. Q3 2025 [...]
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
25/09/2025
TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday [...]
Buying Guide 2025- most effective female libido booster pills in 2025 By OhYes
25/09/2025
When it comes to the best pill for enhancing a woman's sex life, the answer is simple: Oh Yes. This American-made supplement is packed with some of the most effective, all-natural libido-boosting ingredients available, [...]
Medtimo Files Patent Infringement Complaint Against Allurion Technologies
25/09/2025
Complaint Seeks to Protect Medtimo’s Balloon System Technology and Alleges That Allurion Infringes Three Medtimo Patents IRVINE, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medtimo Inc , a wholly owned subsidiary of [...]
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
25/09/2025
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4 th Annual Healthcare Opportunities [...]
CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
25/09/2025
SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
Harrow Launches Harrow Access for All (HAFA)
25/09/2025
HAFA to Expand Harrow’s Innovative Market Access Model Across Ophthalmic Portfolio Program will be available in late 2025 through the HarrowAccess.com Portal NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Harrow ( [...]
Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call
25/09/2025
BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/09/2025
MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the [...]
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
25/09/2025
- Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere - Participants will include adults over 65 years of age in addition to individuals with high-risk co-morbidities and immune [...]
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
25/09/2025
VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, [...]
Buying Guide 2025- Pills to Increase Sex Drive Female 2025 -Start Your Libido Life Today with Oh yes
25/09/2025
Women’s wellness just reached a new level with the launch of the upgraded Oh Yes instant female arousal pills over the counter. This enhanced formula is designed to provide faster, more powerful, and longer-lasting [...]
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
25/09/2025
PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
SoCalBio Investor Conference Sessions to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation
25/09/2025
27th Annual Conference Set for October 1–2 in Orange County Will Unite Leaders From Across the Bioscience Industry LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The Southern California Biomedical Council (SoCalBio) [...]
Buying Guide -Instant female arousal pills over the counter 2025 By OhYes
25/09/2025
Women’s wellness has reached an exciting new milestone with the launch of the upgraded Oh Yes instant female arousal pills, now available over the counter. This advanced formula is designed to deliver faster, stronger, [...]

Pages